281 – 290 of 327
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2004
-
Mark
Physical therapy and imaging outcome measures in a haemophilia population treated with factor prophylaxis: current status and future directions
- Contribution to journal › Article
-
Mark
Economic evaluation: what are we looking for and how do we get there?
- Contribution to journal › Article
-
Mark
Willingness to pay for on-demand and prophylactic treatment for severe haemophilia in Sweden.
- Contribution to journal › Article
-
Mark
Costs of on-demand and prophylactic treatment for severe haemophilia in Norway and Sweden.
- Contribution to journal › Article
- 2003
-
Mark
The pharmacokinetics of clotting factor therapy.
- Contribution to journal › Article
-
Mark
On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
- Contribution to journal › Article
-
Mark
Central venous lines in haemophilia.
- Contribution to journal › Article
-
Mark
Prophylactic therapy for haemophilia: early experience.
- Contribution to journal › Article
-
Mark
Impact of inhibitor epitope profile on the neutralizing effect against plasma-derived and recombinant factor VIII concentrates in vitro.
- Contribution to journal › Article
-
Mark
When to start and when to stop primary prophylaxis in patients with severe haemophilia.
- Contribution to journal › Article
